A National Survey of Glaucoma Specialists on the Preoperative (Trabeculectomy) Management of the Ocular Surface*. (1st November 2016)

• Record Type: Journal Article
• Authors: Tailor, Rajen; Batra, Ruchika; Mohamed, Shabbir
• Is Part Of: Seminars in ophthalmology. Volume 31:Number 6(2016)
• Page Start: 519
• Page End: 525
• Publication Date: 2016-11-01
• Subjects: Glaucoma -- ocular surface disease -- ocular surface inflammation -- preservative -- trabeculectomy; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Eye -- Surgery -- Periodicals; 617.7005
• DOI: 10.3109/08820538.2014.986585
• Languages: English
• ISSNs: 0882-0538

Abstract

Abstract: Background : Preserved anti-glaucoma drops cause ocular surface disease (OSD), which is increasingly being recognized as a likely cause of trabeculectomy failure. Aim : To determine the routine pre-trabeculectomy management of the ocular surface by glaucoma specialists. Methods : A questionnaire consisting of 11 questions was posted to 146 UK glaucoma specialists. Results : The first-time response rate was 43.8%. Regarding routine pre-operative management, 40.6% of specialists use preservative-free drops, 29.7% commence a drop holiday, and 53% advise lid hygiene. 42.1% prescribe lubricants, 50% prescribe topical steroids, 7.8% topical NSAIDs, and 34.4% systemic tetracyclines. 84.4% of specialists change their routine management if OSD is present. Pre-operative optimization of the ocular surface is viewed "necessary" by 48.4% and "beneficial" by 85.9%. Conclusion : A wide variation exists in the routine pre-operative management of the ocular surface. Research to determine the impact of different pre-operative interventions upon trabeculectomy outcomes is required.